1. People's Republic of China Stocks

  2. •

    Consumer Cyclical

  3. •

    Specialty Retail
ECMOHO Limited

ECMOHO Limited

MOHOY
ECMOHO LimitedUS flagOther OTC
0.01
USD
- -
- -
618,555.00Market Cap
ECMOHO Limited
MOHOY
(Other OTC)

Recent

price

0.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
TTM
FRC
3.27
6.63
13.43
8.74
3.29
3.48
Revenue per Share
0.09
0.2
0.09
-0.38
-1.4
-1.48
Basic EPS, GAAP
-0.09
-1.41
-0.61
0.61
0.1
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.66
-0.73
-0.8
-0.94
-2.23
-2.35
Book Value per Share
-0.74
-1.12
3.4
2.26
0.72
0.77
Tangible Book Value per Share
30
30
25
35
40
38
Basic Weighted Avg Shares
98
199
329
305
131
131
Sales/Revenue/Turnover
2.93
3.8
1.54
-3.88
-37.29
-37.29
Operating Margin (%)
1
1
3
2
2
- -
Depreciation Expense
3
6
2
-13
-56
-56
Net Income, GAAP
2.87
6.35
11.43
- -
- -
- -
Effective Tax Rate (%)
2.88
3.08
0.7
-4.36
-42.57
-42.57
Profit Margin (%)
20
37
79
69
23
23
Working Capital
- -
- -
- -
2
1
1
LT Debt
-20
-32
85
80
29
29
Total Equity
- -
- -
7.78
- -
- -
- -
Return on Invested Capital (%)
- -
-92.88
58.2
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
ST Debt
17
12
11
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
145
145
193
Market Capitalization
53
23
15

Working Capital

FRC

•

in mil. unless spec.
Jun'21
Sep'21
Dec'21
Total Current Assets
112
111
87
Cash, Cash Equivalents & STI
43
39
44
Accounts Receivable, Net
38
34
16
Inventories
22
32
22
Total Current Liabilities
51
47
64
Payables & Accruals
33
33
51
ST Debt
17
12
11
Deferred Revenue
1
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-63.69%
Free Cash Flow
- -
- -
-82.17%
Net Income, GAAP
- -
- -
318.49%
Sales/Revenue/Turnover
- -
- -
-57.12%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
61
100
71
72
305
2021
27
43
28
33
131
2022
15
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.13
-0.13
-0.12
- -
-0.38
2021
-0.17
-0.1
-0.09
- -
-1.4
2022
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Similar Companies
JB Hi-Fi Limited (JBHIF)
Kamux Oyj (0RP3.L)
Thakral Corporation Ltd (AWI.SI)
THG Plc (THGPF)
Norbel Baby Co., Ltd (6844.TWO)
Liquidity Services, Inc. (LQDT)
Business
ECMOHO Limited ECMOHO Limited is a Cayman Islands-incorporated investment holding company that operates as an integrated solution provider in China's health and wellness market, offering smart retail, global marketing, customer service, technical warehousing, fulfillment, bonded area warehousing, online store operations, and promotion services to over 200 domestic and international brands. The company distributes non-medical health and wellness products including health supplements and food, mother and child care products, personal care items, household healthcare equipment, cleaning products, healthy food, medical instruments, skin health products, and smart appliances through brand partners' flagship stores, self-operated branded stores on third-party e-commerce platforms such as Douyin and Kuaishou, and small and medium-sized online and offline retailers, serving primarily Chinese consumers and retailers with omni-channel operations, data-driven CRM systems for precision marketing, content production with over 1,000 health experts and KOLs, SaaS-based technology solutions, and a warehousing network exceeding 50,000 square meters across Shanghai, Anhui, Hangzhou, Hong Kong, the United States, and South Korea. Founded in 2011 and headquartered in Shanghai, China, ECMOHO Limited listed on NASDAQ in 2019, became a leading cross-border healthcare e-commerce player in 2014, announced a joint product launch with Harbin Pharmaceutical Group in 2021 for a new iron supplement, established a strategic cooperation with South Korean ChongKunDang Group in 2021 for high-end health foods distribution, invested up to $30 million in Anze Health Pte Ltd in 2020 for Chinese herbal medicine innovation potentially yielding up to 29% equity plus convertible notes, and maintains operations with approximately 300 full-time employees focused on the domestic Chinese market with international brand partnerships.